NEWS HIGHLIGHTSMedia Articles Related to Dovonex (Calcipotriene Topical)
Psoriasis Patients Face Increased Risk of Heart Attacks and Death Source: Medscape Medical News Headlines [2017.09.29] People with psoriasis, a chronic inflammatory disease, may be more likely than others to experience heart attacks and strokes at least in part because inflammation damages their vascular system, a recent study suggests. Reuters Health Information
How Safe Are Various Systemic Therapies for Pediatric Psoriasis? Source: Medscape Dermatology Headlines [2017.09.26] Both methotrexate and TNF inhibitors appear to be safe for the majority of children, though cost is a big consideration. Reuters Health Information
Psoriasis Quiz: Test Your Medical IQ Source: MedicineNet Psoriasis Specialty [2017.09.19] Title: Psoriasis Quiz: Test Your Medical IQ Category: MedicineNet Quiz Created: 4/21/2011 3:23:00 PM Last Editorial Review: 9/19/2017 6:17:30 PM
Severe Psoriasis Linked to Higher Risk of Earlier Death Source: MedicineNet Psoriasis Specialty [2017.09.06] Title: Severe Psoriasis Linked to Higher Risk of Earlier Death Category: Health News Created: 9/5/2017 12:00:00 AM Last Editorial Review: 9/6/2017 12:00:00 AM
Is Psoriasis Contagious? Source: MedicineNet Psoriasis Specialty [2017.09.05] Title: Is Psoriasis Contagious? Category: Diseases and Conditions Created: 6/22/2015 12:00:00 AM Last Editorial Review: 9/5/2017 12:00:00 AM
Published Studies Related to Dovonex (Calcipotriene Topical)
Calcipotriene plus betamethasone dipropionate topical suspension for the
treatment of mild to moderate psoriasis vulgaris on the body: a randomized,
double-blind, vehicle-controlled trial. [2013] and limbs... CONCLUSION: The topical suspension containing calcipotriene plus betamethasone
Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type
psoriasis: results of two multicenter, randomized, double-blind,
vehicle-controlled, phase III clinical trials. [2012] plaque-type psoriasis... CONCLUSIONS: In two identically designed, phase III clinical trials,
A calcipotriene/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8-week, double-blind phase of a clinical trial. [2010.11] The calcipotriene/betamethasone dipropionate two-compound scalp formulation has been shown to be safe and effective in the treatment of scalp psoriasis over 8 weeks, but the patients studied were mainly White and non-Hispanic. The aim of this study was to evaluate the efficacy and safety of the two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients...
Pilot, multicenter, double-blind, randomized placebo-controlled bilateral comparative study of a combination of calcipotriene and nicotinamide for the treatment of psoriasis. [2010.11] BACKGROUND: Calcipotriene has limited efficacy in treating psoriasis. By inhibiting proinflammatory cytokines such as interleukin-12, interleukin-23, and tumor necrosis factor-alfa, nicotinamide may enhance the efficacy of calcipotriene therapy when used in combination. OBJECTIVE: We sought to determine if the combination of nicotinamide with calcipotriene is more effective than either component alone... CONCLUSION: This study provides evidence that using the combination nicotinamide and calcipotriene may provide additional benefit in the topical treatment for patients with psoriasis and may be an adequate steroid-sparing substitute treatment. Copyright (c) 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris. [2010.08] The two-compound ointment (Taclonex/Daivobet/Dovobet ointment) combining calcipotriene 50 microg/g and betamethasone 0.5 mg/g (as dipropionate) is very effective in the treatment of psoriasis vulgaris... No patients using the two-compound ointment for all 52 weeks or alternating four-weekly with calcipotriene had HPA axis suppression.
Clinical Trials Related to Dovonex (Calcipotriene Topical)
Molecular Effects of Topical Calcipotriene on Morphea [Recruiting]
This study will look into how topical treatment with synthetic Vitamin D3, calcipotriene
ointment, used as standard of care, works in patients with morphea. Skin biopsies of morphea
lesions before and after treatment with topical calcipotriene 0. 005% ointment will be
analyzed for changes in RNA and protein. A skin biopsy of unaffected skin will also be
obtained and used for a control. This is an initial study to look at the molecular effects
of topical calcipotriene on human morphea-involved skin. This study will look at the
differences between affected and unaffected skin. This study also will look at clinical
outcomes in morphea patients and determine if there are any clinical predictors for
improvement with the medication.
Actinic Keratosis Study [Recruiting]
The main purpose of this study is to determine the effectiveness of a new combination
therapy for actinic keratosis. This study investigates a new indication for an FDA-approved
topical medication, calcipotriol, for treatment of actinic keratosis, including how well it
works and how safe it is when used in combination with the standard of care medication
(5-fluorouracil) for the skin condition.
Efficacy and Safety Study of Calcipotriol Betamethasone Plus Calcipotriol in Sequential Therapy to Psoriasis [Completed]
LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis [Completed]
The purpose of this study is to compare the safety and effectiveness of a new topical LCD
solution and a commercially available calcipotriol (Vitamin D) cream in reducing the
symptoms of plaque psoriasis and improving the quality of life in adults.
Comparison of Indigo Naturalis Oil Extract and Calcipotriol Solution in Treating Psoriasis [Completed]
The purpose of this study is to compare the efficacy and safety of indigo naturalis oil
extract and calcipotriol solution in the treatment of psoriatic nails, to show that indigo
naturalis oil extract may be a good choice for treating nail psoriasis, and potentially an
effective alternative for those who do not respond well to traditional therapy.
|